| |
| |
|
| Insider
Information: |
Sigal Elliot |
| Relationship: |
Director |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
148,221 |
|
|
Indirect Shares
|
78,638 |
|
|
| Direct
Value |
$5,965,895 |
|
|
|
Indirect Value
|
$5,479,085 |
|
|
| Total
Shares |
226,859 |
|
|
| Total
Value |
$11,444,981 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
EVP, CSO & President R... |
2013-06-03 |
148,221 |
2013-06-03 |
47,079 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2017-06-15 |
0 |
Premium* |
|
|
Spark Therapeutics, Inc. |
ONCE |
Director |
2019-12-17 |
0 |
2015-02-04 |
31,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2012-01-03 |
4 |
B |
$71.35 |
$282 |
I/I |
4 |
4 |
2.02 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2015-02-04 |
4 |
B |
$23.00 |
$115,000 |
D/D |
5,000 |
11,214 |
2.39 |
- |
|
| ONCE |
Spark Therapeutics, Inc. |
Director |
– • – |
2017-10-12 |
4 |
B |
$90.75 |
$2,632 |
D/D |
29 |
11,243 |
2.31 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2003-08-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,219) |
75,024 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2004-02-20 |
4 |
D |
$28.41 |
$30,001 |
D/D |
(1,056) |
98,968 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2004-08-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(939) |
106,085 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2005-02-22 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,150) |
104,935 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP, Global Clin & Pharm Dev |
• – – |
2005-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,038) |
101,897 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2005-11-01 |
4 |
D |
$21.12 |
$81,756 |
D/D |
(3,871) |
165,276 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2006-02-21 |
4 |
D |
$23.09 |
$33,850 |
D/D |
(1,466) |
163,810 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2006-03-01 |
4 |
D |
$22.94 |
$88,801 |
D/D |
(3,871) |
159,939 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2006-03-07 |
4 |
D |
$22.73 |
$42,323 |
D/D |
(1,862) |
186,184 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2006-09-08 |
4 |
D |
$22.96 |
$69,752 |
D/D |
(3,038) |
183,146 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
CSO & President PRI |
• – – |
2006-11-01 |
4 |
D |
$24.76 |
$75,221 |
D/D |
(3,038) |
180,108 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
• – – |
2007-02-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,150) |
178,958 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
• – – |
2007-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,038) |
175,920 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2007-03-02 |
4 |
D |
$26.42 |
$25,865 |
D/D |
(979) |
174,941 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
• – – |
2007-03-06 |
4/A |
D |
$27.01 |
$28,415 |
D/D |
(1,052) |
176,153 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President PRI |
• – – |
2007-03-06 |
4 |
D |
$27.01 |
$28,415 |
D/D |
(1,052) |
176,153 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2007-09-10 |
4/A |
D |
$0.00 |
$0 |
D/D |
(3,882) |
172,271 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2007-09-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,871) |
172,282 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2007-11-01 |
4 |
D |
$29.16 |
$112,908 |
D/D |
(3,872) |
168,410 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2008-03-01 |
4 |
D |
$22.61 |
$44,790 |
D/D |
(1,981) |
166,418 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2008-03-02 |
4 |
D |
$22.61 |
$20,914 |
D/D |
(925) |
165,493 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP, CSO & President R&D |
• – – |
2008-09-10 |
4 |
D |
$21.67 |
$83,906 |
D/D |
(3,872) |
161,621 |
0 |
- |
|
133 Records found
|
|
Page 2 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
